spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Synthetic Biology Congress

Oxford Global Events - Synthetic Biology

8-9 November 2018
London, UK

Oxford Global is proud to present its Synthetic Biology Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.

Our Synthetic Biology Congress will feature over 20 presentations and case studies demonstrating the latest synthetic biology tools and their therapeutic applications.

World renowned experts will give over 20 presentations across 2 interactive streams, including;

·         Synthetic Biology – Tool Development

·         Synthetic Biology – Applications 

View the Agenda here>> https://bit.ly/2Mton5I

This event will be co-located with our highly established 10th Annual Next Generation Sequencing and Clinical Diagnostics Congress, 6th Annual Single Cell Analysis Congress and the 4th Annual Genome Editing Congress 

For further information, prices & group discounts please contact d.dalby@oxfordglobal.co.uk

phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2MtRRQY
email London
 
Print this page
Send to a friend
   
spacer
Industry Events

INTERPHEX 2019

2-4 April 2019, Javits Center, New York

At INTERPHEX, find all of the State-of-the-Art Solutions you need to Cost Effectively Develop and Manufacture Product. INTERPHEX is a premier pharmaceutical, biotechnology, and medical device development and manufacturing event and sponsored by Parenteral Drug Association (PDA). Dedicated to Innovation, Technologies and Knowledge, the show focuses on the entire product development life cycle.
More info >>

Banner of DIA_Europe_Events_95 on Samedan Banner of Drug Delivery Partnership 2018_events_97 on Samedan Banner of PHPL West Coast_events_95 on Samedan

White Papers

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

  The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.
More info >>


News and Press Releases

Charles River Laboratories Continues Commitment to Oncology Drug Discovery

Charles River Laboratories International, Inc. (NYSE: CRL) today announced new additions to the Tumor Model Compendium. Charles River’s Compendium provides access to a comprehensive collection of well-established tumor models for early-stage oncology research.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement